Cargando…

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study

The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jewel Ju Ea, Kocsmár, Ildikó, Buzás, György Miklós, Szirtes, Ildikó, Rusz, Orsolya, Diczházi, Csaba, Szijártó, Attila, Hritz, István, Schaff, Zsuzsa, Kiss, András, Kocsmár, Éva, Lotz, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275651/
https://www.ncbi.nlm.nih.gov/pubmed/34267605
http://dx.doi.org/10.3389/pore.2021.1609863
_version_ 1783721762400239616
author Kim, Jewel Ju Ea
Kocsmár, Ildikó
Buzás, György Miklós
Szirtes, Ildikó
Rusz, Orsolya
Diczházi, Csaba
Szijártó, Attila
Hritz, István
Schaff, Zsuzsa
Kiss, András
Kocsmár, Éva
Lotz, Gábor
author_facet Kim, Jewel Ju Ea
Kocsmár, Ildikó
Buzás, György Miklós
Szirtes, Ildikó
Rusz, Orsolya
Diczházi, Csaba
Szijártó, Attila
Hritz, István
Schaff, Zsuzsa
Kiss, András
Kocsmár, Éva
Lotz, Gábor
author_sort Kim, Jewel Ju Ea
collection PubMed
description The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The proportion of resistant bacteria in the bacterial population (R-fraction) and its predictive role for the use of Cla-based therapies in Cla-heteroresistant infections has not yet been investigated. Our retrospective study analyzed gastric biopsy samples of 62 Hp-positive patients with Cla-heteroresistant infection. Fluorescence In Situ Hybridization technique was used to visualize the coexistence of resistant and susceptible bacteria within one tissue sample. R-fraction was quantified on multichannel microimages by digital morphometry. Resistant bacteria had a patchy distribution within the whole bacterial population causing high diversity among the investigated areas. Patients were subdivided into two major groups according to whether a Cla-based eradication attempt was conducted before or after the biopsy sampling. R-fraction was significantly lower among cases having only one previous Cla-based eradication attempt vs. those that had multiple previous eradications, including at least one Cla-containing therapy (0.41 vs. 0.89, p = 0.0308). Majority of the patients without previous eradication attempt had successful eradication with Cla-containing regimen (59.26%), verified by a negative (13)C-urea breath test or control biopsy. Multivariable model indicated that the therapeutic outcome using Cla-based regimens depended on the bacterial density rather than the R-fraction. Our study raises the potential use of Cla-containing eradication therapies in certain Cla-heteroresistant Hp infections, taking into account the possible predictive role of bacterial density.
format Online
Article
Text
id pubmed-8275651
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82756512021-07-14 Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study Kim, Jewel Ju Ea Kocsmár, Ildikó Buzás, György Miklós Szirtes, Ildikó Rusz, Orsolya Diczházi, Csaba Szijártó, Attila Hritz, István Schaff, Zsuzsa Kiss, András Kocsmár, Éva Lotz, Gábor Pathol Oncol Res Pathology and Oncology Archive The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The proportion of resistant bacteria in the bacterial population (R-fraction) and its predictive role for the use of Cla-based therapies in Cla-heteroresistant infections has not yet been investigated. Our retrospective study analyzed gastric biopsy samples of 62 Hp-positive patients with Cla-heteroresistant infection. Fluorescence In Situ Hybridization technique was used to visualize the coexistence of resistant and susceptible bacteria within one tissue sample. R-fraction was quantified on multichannel microimages by digital morphometry. Resistant bacteria had a patchy distribution within the whole bacterial population causing high diversity among the investigated areas. Patients were subdivided into two major groups according to whether a Cla-based eradication attempt was conducted before or after the biopsy sampling. R-fraction was significantly lower among cases having only one previous Cla-based eradication attempt vs. those that had multiple previous eradications, including at least one Cla-containing therapy (0.41 vs. 0.89, p = 0.0308). Majority of the patients without previous eradication attempt had successful eradication with Cla-containing regimen (59.26%), verified by a negative (13)C-urea breath test or control biopsy. Multivariable model indicated that the therapeutic outcome using Cla-based regimens depended on the bacterial density rather than the R-fraction. Our study raises the potential use of Cla-containing eradication therapies in certain Cla-heteroresistant Hp infections, taking into account the possible predictive role of bacterial density. Frontiers Media S.A. 2021-06-29 /pmc/articles/PMC8275651/ /pubmed/34267605 http://dx.doi.org/10.3389/pore.2021.1609863 Text en Copyright © 2021 Kim, Kocsmár, Buzás, Szirtes, Rusz, Diczházi, Szijártó, Hritz, Schaff, Kiss, Kocsmár and Lotz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pathology and Oncology Archive
Kim, Jewel Ju Ea
Kocsmár, Ildikó
Buzás, György Miklós
Szirtes, Ildikó
Rusz, Orsolya
Diczházi, Csaba
Szijártó, Attila
Hritz, István
Schaff, Zsuzsa
Kiss, András
Kocsmár, Éva
Lotz, Gábor
Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
title Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
title_full Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
title_fullStr Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
title_full_unstemmed Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
title_short Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
title_sort efficacy of clarithromycin depends on the bacterial density in clarithromycin-heteroresistant helicobacter pylori infections: an in situ detected susceptibility and quantitative morphometry-based retrospective study
topic Pathology and Oncology Archive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275651/
https://www.ncbi.nlm.nih.gov/pubmed/34267605
http://dx.doi.org/10.3389/pore.2021.1609863
work_keys_str_mv AT kimjeweljuea efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT kocsmarildiko efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT buzasgyorgymiklos efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT szirtesildiko efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT ruszorsolya efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT diczhazicsaba efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT szijartoattila efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT hritzistvan efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT schaffzsuzsa efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT kissandras efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT kocsmareva efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy
AT lotzgabor efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy